STROVESA Trademark

Trademark Overview


On Friday, November 5, 2021, a trademark application was filed for STROVESA with the United States Patent and Trademark Office. The USPTO has given the STROVESA trademark a serial number of 97110301. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, August 15, 2024. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The STROVESA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of alimentary, anti-parasitic, autoimmune, blood-related, cancer, cardiovascular, central nervous system, dermatological, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, musculo-skeletal, neurological, opthalmological, pain, renal, metabolic, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology
strovesa

General Information


Serial Number97110301
Word MarkSTROVESA
Filing DateFriday, November 5, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, August 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of alimentary, anti-parasitic, autoimmune, blood-related, cancer, cardiovascular, central nervous system, dermatological, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, musculo-skeletal, neurological, opthalmological, pain, renal, metabolic, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Tuesday, November 9, 2021NEW APPLICATION ENTERED
Monday, November 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 25, 2022ASSIGNED TO EXAMINER
Wednesday, May 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 14, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 14, 2023SOU EXTENSION 1 FILED
Tuesday, February 14, 2023SOU EXTENSION 1 GRANTED
Thursday, February 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 16, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 16, 2023SOU EXTENSION 2 FILED
Wednesday, August 16, 2023SOU EXTENSION 2 GRANTED
Friday, August 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 20, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 20, 2024SOU EXTENSION 3 FILED
Tuesday, February 20, 2024SOU EXTENSION 3 GRANTED
Thursday, August 15, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 15, 2024SOU EXTENSION 4 GRANTED
Thursday, August 15, 2024SOU EXTENSION 4 FILED